Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States

Emily P. Zeitler, Christopher J. Ronk, Alex Cockerham, Samuel Huse, David S. McKindley, Michael H. Kim

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: To summarize healthcare resource utilization (HCRU) in patients with newly diagnosed (incident) paroxysmal or persistent atrial fibrillation (AF). Methods: This retrospective, observational cohort study assessed HCRU among patients with incident paroxysmal or persistent AF using data from 1 January 2015 to 30 September 2019 in the IBM MarketScan® Research Databases. Results: A total of 50,796 patients were identified in the overall incident AF cohort. Rates of all-cause inpatient hospital stays, all-cause emergency room visits, and all-cause outpatient visits in the overall incident cohort were 46.8, 114.7, and 2,752.7 events per 100 patient-years (PY), respectively. Rates of cardiovascular-related inpatient stays for the overall population were 11.3 events per 100 PY. During follow-up, 50.4% of the overall cohort filled prescriptions for direct-acting oral anticoagulants and 5.0% had catheter ablation. Conclusions: Advances in anticoagulation and ablation have been realized since previously published HCRU analyses of patients with atrial fibrillation. This update suggests that HCRU among patients with incident AF in the US remains high with some subgroups of patients receiving more specialized care.

Original languageEnglish (US)
Pages (from-to)763-771
Number of pages9
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume22
Issue number5
DOIs
StatePublished - 2022

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States'. Together they form a unique fingerprint.

Cite this